Home › NIH Launches $20M Competition for New Antimicrobial Resistance Diagnostics

NIH Launches $20M Competition for New Antimicrobial Resistance Diagnostics

Sep 08, 2016

NEW YORK (GenomeWeb) – The National Institutes of Health today launched a $20 million competition to promote the development of novel point-of-care in vitro diagnostics to detect and distinguish antibiotic-resistant bacteria.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Dec
12
Featured Webinar

Precision Metagenomics to Identify Patients at Risk for Invasive Infection

This webinar will discuss the use of shotgun metagenomics to identify children at risk of hospital-acquired infection.

What's Popular?

In Molecular Diagnostics

  1. Guardant Health to Launch Cell-Free DNA Assay for Cancer Recurrence Monitoring in 2019

    Premium

  2. Legislators Release New Draft Bill Incorporating FDA Ideas for Diagnostics Regulation

  3. SABCS 2018 Features Molecular Diagnostics Research

  4. Novacyt to Sell Cytology, Clinical Lab Units

  5. PredictImmune Gains CE-IVD Mark for IBD Test

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.